Mubadala and Khalifa University start pharma innovation program
Mubadala Investment Company, in partnership with Khalifa University of Science and Technology, launched the "Pharmaceutical Innovation Program" with the aim of advancing scientific research and transforming it into innovative products to support the healthcare sector in the UAE. The program includes funding for research projects in cardiovascular and metabolic diseases, neurological disorders, and tumors, along with the establishment of a research and development laboratory within the College of Medicine at Khalifa University. This collaboration seeks to localize the pharmaceutical industry, reduce dependence on imports, and develop national talents to support a sustainable knowledge-based economy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)